Bilberry (Vaccinium myrtillus)

Vaccinium myrtillus
Evidence Level
Moderate
2 Clinical Trials
5 Documented Benefits
3/5 Evidence Score

Bilberry is a wild-harvested European relative of the blueberry whose fruit contains exceptionally high concentrations of anthocyanins — particularly delphinidin, cyanidin, and malvidin glycosides — that selectively accumulate in ocular and vascular tissue. Used by British RAF pilots in WWII who reportedly ate bilberry jam before night missions to improve night vision, bilberry has been studied extensively for eye health, vision improvement, retinal protection, and microvascular support with an impressive modern clinical evidence base.

Studied Dose 80–480 mg/day standardized extract (25% anthocyanosides = 20–120 mg anthocyanins); eye health: 160–480 mg/day; vascular: 160–320 mg/day
Active Compound Anthocyanins (anthocyanosides, ≥25% standardized) — Mirtoselect® (Indena) and Tegens® are the most clinically validated bilberry extracts

Night vision and dark adaptation

Bilberry anthocyanins regenerate rhodopsin (the light-sensitive visual pigment in rod photoreceptors) more rapidly after light exposure and protect rod cells from oxidative stress — improving the speed and quality of dark adaptation. While WWII anecdotes may be exaggerated, clinical studies confirm meaningful improvements in night vision and visual acuity under low-light conditions.

Retinal protection and diabetic retinopathy

Bilberry anthocyanins accumulate selectively in retinal tissue and protect the blood-retinal barrier from oxidative damage, reduce retinal capillary leakage, and inhibit VEGF-driven neovascularization. Clinical studies show bilberry slows diabetic retinopathy progression and improves visual acuity in early diabetic eye disease.

Microvascular health and chronic venous insufficiency

Like other OPC-containing extracts, bilberry strengthens capillary walls, reduces microvascular permeability, and improves microcirculation. Clinical trials show significant improvements in chronic venous insufficiency symptoms including leg edema, pain, and heaviness — effects attributed to collagen stabilization in vessel walls.

Antioxidant protection and anti-inflammatory activity

Bilberry anthocyanins have among the highest ORAC antioxidant values of any food-derived extract, directly scavenging free radicals and activating Nrf2-mediated antioxidant enzyme induction. Anti-inflammatory effects include NF-κB inhibition, COX-2 reduction, and cytokine suppression in ocular and vascular tissue.

Blood sugar regulation

Bilberry extract significantly reduces postprandial blood glucose and improves insulin sensitivity through alpha-glucosidase inhibition and GLUT4 upregulation. Clinical studies in pre-diabetic and T2DM patients show meaningful glycemic improvements, with the berry-derived anthocyanin profile providing superior metabolic effects to synthetic anthocyanin isolates.

1

Rhodopsin regeneration and visual photoreception

Bilberry anthocyanins specifically bind rhodopsin in rod photoreceptors and accelerate its regeneration after photobleaching by light exposure. They also protect the outer retinal photoreceptor layer from oxidative damage via mitochondrial protection and free radical scavenging in retinal tissue — explaining the evidence for improved dark adaptation.

2

Capillary wall collagen stabilization

Bilberry OPCs cross-link and stabilize collagen fibers in capillary basement membranes, reducing pericyte loss and endothelial permeability. This structural collagen protection explains the reduction in retinal hemorrhages, reduced capillary leakage, and improved venous wall integrity observed clinically.

3

VEGF inhibition and anti-angiogenic activity

Bilberry anthocyanins inhibit vascular endothelial growth factor (VEGF) signaling — the primary driver of pathological neovascularization in diabetic retinopathy and age-related macular degeneration. VEGF inhibition reduces abnormal new blood vessel formation and the associated retinal damage.

1
Bilberry Extract and Diabetic Retinopathy — Clinical Study
PubMed

Prospective clinical study of standardized bilberry extract (Tegens®, 160 mg twice daily) vs. no treatment in 40 patients with diabetic and/or hypertensive retinopathy.

40 patients with diabetic/hypertensive retinopathy. 1-month treatment period.

Bilberry extract significantly reduced retinal hemorrhages, improved retinal capillary permeability measures, and improved visual acuity in 77.5% of treated patients. No changes in untreated control group. Well-tolerated.

2
Bilberry Anthocyanins and Postprandial Glucose — RCT
PubMed

Randomized crossover study examining bilberry extract effects on postprandial glucose and insulin in 40 healthy adults.

40 healthy adults. Acute crossover glucose tolerance test.

Bilberry extract significantly reduced postprandial glucose peak, glucose AUC, and insulin response vs. placebo. Alpha-glucosidase inhibitory activity confirmed. Supports bilberry for metabolic health applications alongside eye health.

Common Potential side effects

Very well tolerated; excellent safety record across clinical use
Mild GI effects at high doses
Dark-colored stools and urine possible — harmless anthocyanin pigment excretion

Important Drug interactions

Anticoagulants (warfarin) — anthocyanins have mild antiplatelet activity; monitor INR
Antidiabetic medications — additive glucose-lowering; monitor blood sugar
Iron supplements — polyphenols reduce non-heme iron absorption; separate by 2 hours